Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Farrugia, Me"" wg kryterium: Autor


Wyświetlanie 1-14 z 14
Tytuł:
Immune-Mediated Neuropathies: Pathophysiology and Management.
Autorzy:
Shastri A; Central and North West London NHS Foundation Trust, London NW1 3AX, UK.
Al Aiyan A; Department of Veterinary Medicine, UAE University, Al Ain P.O. Box 15551, United Arab Emirates.
Kishore U; Department of Veterinary Medicine, UAE University, Al Ain P.O. Box 15551, United Arab Emirates.
Farrugia ME; Department of Neurology, Institute of Neurological Sciences, Southern General Hospital, Glasgow G51 4TF, UK.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2023 Apr 14; Vol. 24 (8). Date of Electronic Publication: 2023 Apr 14.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Guillain-Barre Syndrome*
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating*
Polyneuropathies*
Neuritis*
Animals ; Autoantibodies ; Inflammation
Czasopismo naukowe
Tytuł:
Infantile pemphigoid treated without oral corticosteroids.
Autorzy:
Farrugia ME; Department of Dermatology, NHS Lothian, Edinburgh, UK.
Ball SL; Department of Dermatology, NHS Lothian, Edinburgh, UK.
Tidman MJ; Department of Dermatology, NHS Lothian, Edinburgh, UK.
Pokaż więcej
Źródło:
Clinical and experimental dermatology [Clin Exp Dermatol] 2019 Oct; Vol. 44 (7), pp. 832-833. Date of Electronic Publication: 2019 Jun 12.
Typ publikacji:
Case Reports; Letter
MeSH Terms:
Dermatologic Agents/*administration & dosage
Mometasone Furoate/*administration & dosage
Pemphigoid, Bullous/*drug therapy
Acrodermatitis/etiology ; Acrodermatitis/pathology ; Administration, Oral ; Administration, Topical ; Anti-Bacterial Agents/administration & dosage ; Anti-Bacterial Agents/therapeutic use ; Dermatologic Agents/therapeutic use ; Erythromycin/administration & dosage ; Erythromycin/therapeutic use ; Humans ; Infant ; Male ; Mometasone Furoate/therapeutic use ; Pemphigoid, Bullous/diagnosis ; Pemphigoid, Bullous/pathology ; Treatment Outcome
Raport
Tytuł:
The Association of British Neurologists' myasthenia gravis guidelines.
Autorzy:
Sussman J; Department of Neurology, Greater Manchester Neuroscience Centre, Salford, Greater Manchester, UK.
Farrugia ME; Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, UK.
Maddison P; Department of Neurology, Nottingham University Hospitals NHS Trust, Queens Medical Centre, Nottingham, Nottinghamshire, UK.
Hill M; Department of Neurology, Morriston Hospital, Swansea, Wales, UK.
Leite MI; Department of Neurology, John Radcliffe Hospital, Oxford, UK.
Hilton-Jones D; Department of Neurology, John Radcliffe Hospital, Oxford, UK.
Pokaż więcej
Źródło:
Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2018 Jan; Vol. 1412 (1), pp. 166-169. Date of Electronic Publication: 2017 Nov 09.
Typ publikacji:
Journal Article; Practice Guideline
MeSH Terms:
Myasthenia Gravis/*therapy
Evidence-Based Medicine ; Expert Testimony ; Humans ; Neurology ; Societies, Medical ; United Kingdom
Czasopismo naukowe
Tytuł:
Correction: Elevated plasma levels of cardiac troponin-I predict left ventricular systolic dysfunction in patients with myotonic dystrophy type 1: A multicentre cohort follow-up study.
Autorzy:
Hamilton MJ
Robb Y
Cumming S
Gregory H
Duncan A
Rahman M
McKeown A
McWilliam C
Dean J
Wilcox A
Farrugia ME
Cooper A
McGhie J
Adam B
Petty R
Longman C
Findlay I
Japp A
Monckton DG
Denvir MA
Pokaż więcej
Corporate Authors:
Scottish Myotonic Dystrophy Consortium
Źródło:
PloS one [PLoS One] 2017 Apr 06; Vol. 12 (4), pp. e0175615. Date of Electronic Publication: 2017 Apr 06 (Print Publication: 2017).
Typ publikacji:
Journal Article; Published Erratum
Czasopismo naukowe
Tytuł:
Elevated plasma levels of cardiac troponin-I predict left ventricular systolic dysfunction in patients with myotonic dystrophy type 1: A multicentre cohort follow-up study.
Autorzy:
Hamilton MJ; West of Scotland Clinical Genetics Service, Queen Elizabeth University Hospital, Glasgow, United Kingdom.; Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Robb Y; Clinical Genetics Service, Western General Hospital, Edinburgh, United Kingdom.
Cumming S; Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Gregory H; North of Scotland Clinical Genetics Service, Ashgrove House, Foresterhill Health Campus, Aberdeen, United Kingdom.
Duncan A; West of Scotland Clinical Genetics Service, Queen Elizabeth University Hospital, Glasgow, United Kingdom.
Rahman M; West of Scotland Clinical Genetics Service, Queen Elizabeth University Hospital, Glasgow, United Kingdom.
McKeown A; West of Scotland Clinical Genetics Service, Queen Elizabeth University Hospital, Glasgow, United Kingdom.
McWilliam C; Human Genetics Unit, Ninewells Hospital, Dundee, United Kingdom.
Dean J; North of Scotland Clinical Genetics Service, Ashgrove House, Foresterhill Health Campus, Aberdeen, United Kingdom.
Wilcox A; West of Scotland Clinical Genetics Service, Queen Elizabeth University Hospital, Glasgow, United Kingdom.
Farrugia ME; Department of Neurology, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, United Kingdom.
Cooper A; Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
McGhie J; Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Adam B; Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Petty R; Department of Neurology, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, United Kingdom.
Longman C; West of Scotland Clinical Genetics Service, Queen Elizabeth University Hospital, Glasgow, United Kingdom.
Findlay I; Inherited Cardiac Conditions Service, Queen Elizabeth University Hospital, Glasgow, United Kingdom.
Japp A; Centre for Cardiovascular Science, Queens Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.
Monckton DG; Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Denvir MA; Centre for Cardiovascular Science, Queens Medical Research Institute, University of Edinburgh, Edinburgh, United Kingdom.
Pokaż więcej
Corporate Authors:
Scottish Myotonic Dystrophy Consortium
Źródło:
PloS one [PLoS One] 2017 Mar 21; Vol. 12 (3), pp. e0174166. Date of Electronic Publication: 2017 Mar 21 (Print Publication: 2017).
Typ publikacji:
Journal Article; Multicenter Study
MeSH Terms:
Myocardium/*pathology
Myotonic Dystrophy/*pathology
Troponin I/*blood
Ventricular Dysfunction, Left/*blood
Ventricular Dysfunction, Left/*diagnosis
Adult ; Aged ; Biomarkers/blood ; Echocardiography ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Myotonin-Protein Kinase/genetics ; Young Adult
Czasopismo naukowe
Tytuł:
Myasthenia gravis seronegative for acetylcholine receptor antibodies.
Autorzy:
Vincent A; Neurosciences Group, Weatherall Institute of Molecular Medicine and Department of Clinical Neurology, John Radcliffe Hospital, Oxford, United Kingdom. />Leite MI
Farrugia ME
Jacob S
Viegas S
Shiraishi H
Benveniste O
Morgan BP
Hilton-Jones D
Newsom-Davis J
Beeson D
Willcox N
Pokaż więcej
Źródło:
Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2008; Vol. 1132, pp. 84-92.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antibodies/*immunology
Myasthenia Gravis/*immunology
Myasthenia Gravis/*metabolism
Receptors, Cholinergic/*immunology
Receptors, Cholinergic/*metabolism
Animals ; Antibodies/blood ; Electrophysiology ; Humans ; Myasthenia Gravis/epidemiology ; Myasthenia Gravis/pathology ; Receptor Protein-Tyrosine Kinases/metabolism
Czasopismo naukowe
    Wyświetlanie 1-14 z 14

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies